Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by JordanDeeon Jan 03, 2018 9:06pm

99 Views

Post# 27276279

RE:PANIC WAY OVERBLOWN --- Investing clearly not for everyone.

Strongly agree. We were all there once, and learned. I do hope for the sake of the new investors that they learn to be patient sooner than later because the opportunities to get in at the ground floor are far from few now, and we're merely months away from legalization.

Bullboard Posts

Optimi Health makes commercial entry into Australia